The molecular characteristics and clinical outcomes of head and neck cancer vary widely. In this Review, the authors focus on established and emerging biomarkers that are most relevant to nasopharyngeal carcinoma and head and neck squamous-cell carcinoma (HNSCC). Applications and limitations of currently established biomarkers are discussed, and ongoing efforts to shift from prognostic to predictive biomarker development with the goal of delivering individualized cancer therapy is highlighted.
- Hyunseok Kang
- Ana Kiess
- Christine H. Chung
